Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2007
08/08/2007EP1532111B1 2,5-disubstituted 3-mercaptopentanoic acid
08/08/2007EP0927180B1 Heterocyclic compounds and their use for isolating nucleic acids
08/08/2007CN1330646C Prucalopride-N-oxide
08/08/2007CN1330645C Benzofuran-2-ones as colorants for organic materials
08/08/2007CN1330644C Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide
08/08/2007CN1330640C Substituted bicyclic derivatives for the treatment of abnormal cell growth
08/08/2007CN1330638C Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them
08/08/2007CN1330637C Novel compounds of family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents
08/08/2007CN1330307C Indole, azaindole and related heterocyclic amidopiperazine derivatives
08/08/2007CN101014588A Pyrrole derivatives, their preparation and their therapeutic use
08/08/2007CN101014574A Hiv整合酶抑制剂 Hiv integrase inhibitors
08/08/2007CN101014572A Carbamoylpyridone derivative having HIV integrase inhibitory activity
08/08/2007CN101012222A Method of synthesizing Itraconazole
08/08/2007CN101012213A Derivative of genistein and its preparing method and use
08/08/2007CN101012203A 1,2,4-triazol derivatives, method for preparing the same
08/08/2007CN101012193A Novel CB 1 receptour inverse agonists
08/07/2007US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
08/07/2007US7253205 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia
08/07/2007US7253203 Indoline derivatives
08/07/2007US7253202 Substituted benzodioxepines
08/07/2007US7253199 Azole derivatives and pharmaceutical compositions containing them
08/07/2007US7253198 Hydroxyethylamine derivatives for the treatment of Alzheimer's disease
08/07/2007US7253190 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders
08/07/2007US7253187 Heterocyclic inhibitors of ERK2 and uses thereof
08/07/2007US7253186 N-substituted piperidine derivatives as serotonin receptor agents
08/07/2007US7253184 4-Phenoxyanilino-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes
08/07/2007US7253183 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation
08/07/2007US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
08/07/2007US7253170 Pyrazole-amine compounds useful as kinase inhibitors
08/07/2007US7253159 Antigen and lysine acylated protein; cytokines; drug screening; liquid chromatography
08/07/2007US7253007 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
08/07/2007US7252835 Administering 4-oxo-8-(4-(4- phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl )4H-1-benzopyran or salt or hydrate for therapy of sinusitis
08/07/2007CA2317589C Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
08/07/2007CA2247734C New piperazine and piperidine compounds selectively binding dopamine and serotonin receptors
08/02/2007WO2007087419A2 Substituted 3-(5-membered unsaturated heterocyclyl) -1, 3-dihydro-indol-2-one derivatives as tyrosine kinase inhibitors for the treatment of cancer
08/02/2007WO2007086799A1 Amide substituted quinolines
08/02/2007WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K
08/02/2007WO2007086016A1 Tetrahydropyrane antibiotics
08/02/2007WO2007085558A1 Use of 2-imidazoles for the treatment of cns disorders
08/02/2007WO2007085556A2 Use of 4-imidazole derivatives for cns disorders
08/02/2007WO2007085540A1 1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
08/02/2007WO2007060408A3 L-phenylalanine derivatives and their use as integrin antagonists
08/02/2007WO2007053131A3 Acrylamide derivatives as antibiotic agents
08/02/2007WO2006127815A3 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
08/02/2007WO2006081391A3 Compounds for inflammation and immune-related uses
08/02/2007WO2006045096A3 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
08/02/2007WO2005065150A3 Mutagenic heterocycles
08/02/2007US20070179308 Process for preparing amophous (4r-cis)-6-[2-[3-phenyl-4-(Phenylcarbamoyl)-2-4-Fluorophenyl)-5-(1-Methylethyl)-Pyrrol-1-YL]-Ethyl]-2,2-Dimethyl-[1,3]-Dioxane-4-YL-Acetic Acid
08/02/2007US20070179297 Chemical compounds
08/02/2007US20070179192 Thrombopoietin mimetics
08/02/2007US20070179187 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
08/02/2007US20070179184 Novel m3 muscarinic acetylcholine receptor antagonists
08/02/2007US20070179180 Novel m3 muscarinic acetylcholine receptor antagonists
08/02/2007US20070179154 Coumarin derivatives, process for their production and use thereof
08/02/2007US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
08/02/2007US20070179146 2-{4-[3-(3,4-dimethoxy-phenyl)-5.5-dimethyl-6-oxa-5,6-dihydro-4H-pyridazin-1-yl]-piperidine-1-sulfonyl}-benzonitrile; low toxicity, high bioavailability, side effects reduction; antiinflammatory agents; antiallergenic; respiratory disorders
08/02/2007US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
08/02/2007US20070179132 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
08/02/2007US20070179131 Novel M3 Muscarinic Acetylcholine Receptor Antagonists
08/02/2007US20070179129 Opioid receptor antagonists
08/02/2007US20070179120 Hydroxyl compounds and compositions for cholesterol management and related uses
08/02/2007US20070176544 Coumarin compound, material for light emitting device and organic electroluminescent device
08/02/2007CA2640375A1 Pyrimidine derivatives
08/02/2007CA2637933A1 Indole sulfonamide modulators of progesterone receptors
08/02/2007CA2637312A1 Use of substituted 2-imidazole of imidazoline derivatives
08/02/2007CA2637308A1 Use of 4-imidazole derivatives for cns disorders
08/02/2007CA2637261A1 Use of 2-imidazoles for the treatment of cns disorders
08/02/2007CA2635126A1 Tetrahydropyrane antibiotics
08/01/2007EP1813611A1 1-substituted-3- beta-d-glucopyranosylated nitrogenous hetero- cyclic compounds and medicines containing the same
08/01/2007EP1813284A1 Pharmaceutical composition
08/01/2007EP1812425A2 C-fms kinase inhibitors
08/01/2007EP1812406A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
08/01/2007EP1812405A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs
08/01/2007EP1812389A1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/01/2007EP1811993A2 Modulators of crth2, cox-2 and faah
08/01/2007EP1603928B1 Pyridinium-betain compounds and their use
08/01/2007EP1581505B1 Pyridazinone derivatives as gsk-3beta inhibitors
08/01/2007EP1565456A4 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/01/2007EP1560811B1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
08/01/2007EP1534704B1 Process for preparing 5-(4-fluorophenyl)-1-¬2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl|-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
08/01/2007EP1487822B1 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
08/01/2007EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof
08/01/2007EP1373194B1 BENZAMIDE INHIBITORS OF FACTOR Xa
08/01/2007EP1294714B1 Thrombin receptor antagonists
08/01/2007EP1018879B1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
08/01/2007CN1329407C Method for synthesizing beta-L-5-fluoro-2',3'-dideoxy-2',3'-didehydrocytidine
08/01/2007CN1329389C Novel compounds and their use
08/01/2007CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors
08/01/2007CN1329386C Substituted phenylacetamides and their use as glucokinase activators
08/01/2007CN1329380C Trisresorcinyltriazines
08/01/2007CN1329378C Compounds useful to treat retroviral infections
08/01/2007CN1329374C Compound as CCR5 agonist
08/01/2007CN101010318A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
08/01/2007CN101010315A Substituted pyrazolyl urea derivatives useful in the treatment of cancer
08/01/2007CN101010311A Azo compounds and process for production thereof
08/01/2007CN101010296A Piperazine derivatives of alkyhydroxy indole
08/01/2007CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/01/2007CN101007802A Mediators of hedgehog signaling pathways, compositions and uses related thereto
08/01/2007CN101007784A Antibacterial agents
07/2007
07/31/2007USRE39754 Benzamide derivatives and pharmaceutical compositions containing same